Fields, J. A., Swinton, M., Qvale, E. M., Marquine, M. J., Gough, S., Soontornniyomkij, B., . . . Desplats, P. (2018). Alterations in brain TREM2 and Amyloid‐β levels are associated with neurocognitive impairment in HIV‐infected persons on antiretroviral therapy. Journal of Neurochemistry, 147(6), 784. https://doi.org/10.1111/jnc.14582
Chicago Style (17th ed.) CitationFields, Jerel Adam, et al. "Alterations in Brain TREM2 and Amyloid‐β Levels Are Associated with Neurocognitive Impairment in HIV‐infected Persons on Antiretroviral Therapy." Journal of Neurochemistry 147, no. 6 (2018): 784. https://doi.org/10.1111/jnc.14582.
MLA (9th ed.) CitationFields, Jerel Adam, et al. "Alterations in Brain TREM2 and Amyloid‐β Levels Are Associated with Neurocognitive Impairment in HIV‐infected Persons on Antiretroviral Therapy." Journal of Neurochemistry, vol. 147, no. 6, 2018, p. 784, https://doi.org/10.1111/jnc.14582.